News & Perspective

Oct 02, 2012

Oct 02, 2012

Report details Ohio H3N2v cases, cautions about pig barns

(CIDRAP News) – Eleven of 16 hospitalized US cases of variant H3N2 (H3N2v) swine-origin influenza this past summer occurred in Ohio, and 10 of those were in children, according to a report that also suggests that even healthy people stay away from pigs at fairs to avoid flu infection.

Sep 13, 2012

Sep 13, 2012

BioWatch program faces GAO, congressional scrutiny

Disclosure: The University of Minnesota's Center for Infectious Disease Research and Policy, which publishes CIDRAP News, has produced training programs and materials for the BioWatch program. The news team has no involvement in the center's BioWatch work.

Aug 21, 2012

Aug 21, 2012

H3N2v infections spark debate about barring pigs from fairs

(CIDRAP News) – The type of flu transmission occurring mainly in young people directly exposed to pigs at fairs this summer is unprecedented, and health officials should consider keeping pigs away from the events, according to one infectious disease expert who has gone on record with his concerns.

Aug 17, 2012

Aug 17, 2012

Public health officials respond to critique of BioWatch

In the wake of a newspaper investigation that questioned the value of the federal BioWatch program for detecting dangerous airborne pathogens, some public health officials familiar with the program acknowledge that it's far from perfect, but they say it's not time to scrap it.

Aug 09, 2012

Aug 09, 2012

Illinois confirms novel H3N2 case as national total hits 152

(CIDRAP News) – The number of recent human cases of swine-origin variant H3N2 influenza (H3N2v) in recent weeks climbed to 152 today as Illinois reported its first case and Indiana announced more infections.

Jul 31, 2012

Jul 31, 2012

Fauci urges continuing pause on risky H5N1 studies

(CIDRAP News) – The head of the US agency that funds much influenza research today called on scientists to continue their voluntary moratorium on certain kinds of potentially hazardous H5N1 research, saying they need to better address public concerns about the studies, according to news reports from a flu meeting in New York City.

Jul 27, 2012

Jul 27, 2012

Experts urge holding off on hazardous H5N1 studies

(CIDRAP News) – As leading influenza researchers prepare to meet in New York City next week, several eminent life-sciences authorities are calling for continuation of a moratorium on studies involving lab-modified H5N1 viruses with increased transmissibility, according to a story today in the British newspaper The Independent.

Jul 24, 2012

Jul 24, 2012

WHO offers some guidance on risky H5N1 studies

(CIDRAP News) – The World Health Organization (WHO) has offered some brief, general guidance on safety and security in research on laboratory-modified H5N1 viruses, mainly stressing that researchers should follow existing guidelines and gain authorization from their governments.

Jun 21, 2012

Jun 21, 2012

Fouchier study reveals changes enabling airborne spread of H5N1

(CIDRAP News) – A study showing that it takes as few as five mutations to turn the H5N1 avian influenza virus into an airborne spreader in mammals—and that launched a historic debate on scientific accountability and transparency—was released today in Science, spilling the full experimental details that many experts had sought to suppress out of concern that publishing them could lead to the unleashing of a dangerous virus.

May 04, 2012

May 04, 2012

NIH rejects charge it slanted the H5N1 agenda for NSABB

(CIDRAP News) – In a lengthy letter, a National Institutes of Health (NIH) official has rejected recent charges that the agency planned a biased meeting agenda in an effort to induce the National Science Advisory Board for Biosecurity (NSABB) to act as it did in voting for full publication of two much-debated studies on H5N1 virus transmissibility.

Pages

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»